Insider · CIK 0002056554
Michael Komasinski
Files at CRTO (Criteo S.A.). First filing -, latest -.
Michael Komasinski files SEC Form 4 as CEO and director at CRTO (Criteo S.A.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Michael Komasinski has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | CRTO Criteo S.A. | AGrant or award Ordinary Shares | +141,700 | $0.00 | $0 | 361,106 | Mar 16, 2026 |
| Feb 26, 2026 | CRTO Criteo S.A. | AGrant or award Ordinary Shares | +42,771 | $0.00 | $0 | 219,406 | Mar 2, 2026 |
| Dec 22, 2025 | CRTO Criteo S.A. | AGrant or award Ordinary Shares | +125,000 | $0.00 | $0 | 176,635 | Dec 23, 2025 |
| Feb 28, 2025 | CRTO Criteo S.A. | AGrant or award Ordinary Shares | +51,635 | $0.00 | $0 | 51,635 | Mar 4, 2025 |
Questions about Michael Komasinski
Answered from the filings on this page, as of the latest one.
Is Michael Komasinski buying or selling?
Michael Komasinski has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Michael Komasinski's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael Komasinski has 0.
Where does Michael Komasinski file Form 4?
Michael Komasinski has filed Form 4 at CRTO (Criteo S.A.) as CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.